Article
Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.
Oncotarget - 15 Mar 2016
Carrero Zunamys I, Kollareddy Madhusudhan, Chauhan Krishna M, Ramakrishnan Gopalakrishnan, Martinez Luis A
Abstract excerpt
Mutations in the tumor suppressor gene TP53 contribute to the development of approximately half of all human cancers. One mechanism by which mutant p53 (mtp53) acts is through interaction with other transcription factors, which can either enhance or repress the transcription of their target genes. Mtp53 preferentially interacts with the erythroblastosis virus E26 oncogene homologue 2 (ETS2), an ETS transcription...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
